Dark
Light
System
Institutional Investment Manager
CASDIN CAPITAL, LLC
CASDIN CAPITAL, LLC (CIK: 0001534261). Institutional holdings reported to the SEC.

Institutional Holdings (2016Q3)
Portfolio Summary: 26 holdings with a total value of $123,498,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 AGIOS PHARMACEUTICALS INC 282,443 14,919,000 12.08%
2 SAGE THERAPEUTICS 266,500 12,272,000 9.94%
3 FOUNDATION MEDICINE INC COM 415,000 9,690,000 7.85%
4 Evolent Health, Inc. 385,000 9,479,000 7.68%
5 BLUEPRINT MEDICINES CORP COM 287,000 8,524,000 6.90%
6 LOXO ONCOLOGY INC COM 291,000 7,618,000 6.17%
7 GENMARK DIAGNOSTICS INC COM 625,000 7,375,000 5.97%
8 SPARK THERAPEUTICS INC 93,500 5,616,000 4.55%
9 GLOBAL BLOOD THERAPEUTICS IN COM 240,000 5,532,000 4.48%
10 KITE PHARMA INCORPORATED 90,000 5,027,000 4.07%
11 BLUEBIRD BIO INCORPORATED 60,000 4,067,000 3.29%
12 CLOVIS ONCOLOGY INC 110,000 3,966,000 3.21%
13 VOYAGER THERAPEUTICS INC 276,500 3,321,000 2.69%
14 EPIZYME INC COM 295,000 2,903,000 2.35%
15 EXACT SCIENCES CORP 155,000 2,878,000 2.33%
16 ALNYLAM PHARMACEUTICALS INC 39,000 2,643,000 2.14%
17 ALLSCRIPTS HEALTHCARE 200,000 2,634,000 2.13%
18 MYOKARDIA INC 160,000 2,614,000 2.12%
19 GENOMIC HEALTH INC COM 90,000 2,603,000 2.11%
20 MEDGENICS INC 375,000 2,089,000 1.69%
21 CYTOMX THERAPEUTICS INC COM 127,500 1,999,000 1.62%
22 ISHARES TR 5,000 1,447,000 1.17%
23 IGNYTA INC COM 195,000 1,227,000 0.99%
24 IONIS PHARMACEUTICALS INC 33,000 1,209,000 0.98%
25 EDITAS MEDICINE INCORPORATED 85,470 1,152,000 0.93%
26 SYROS PHARMACEUTICALS INC 50,000 694,000 0.56%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-004290, filed 2016.11.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.